INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Results

26,449 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
11
MP
Mazzara PhilipGeneral Counsel and Secretary
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$55K
500 sh
Apr 1, 2026Apr 3, 2026
Page 450 of 662
← PrevNext →
traded Apr 1, 2026
+2d
SEC Form 4

Evidence

10
MA
McGrane AshleyGeneral Counsel and Corp Sec
GTMZoomInfo Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$41K
6,959 sh
Apr 2, 2026Apr 3, 2026
traded Apr 2, 2026
+1dSEC Form 4

Evidence

10
RM
Rosett MaxChief Financial Officer
IMNMImmunome Inc.
Open-market sale · 10b5-1 plan
SELL$30K
1,344 sh
Apr 2, 2026Apr 3, 2026
traded Apr 2, 2026
+1dSEC Form 4

Evidence

8
DS
Dutt SubirChief Sales Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$21K
509 sh
Apr 2, 2026Apr 3, 2026
traded Apr 2, 2026
+1dSEC Form 4

Evidence

8
SS
Sahni Sanjeev SinghPresident
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$5,030
124 sh
Apr 2, 2026Apr 3, 2026
traded Apr 2, 2026
+1dSEC Form 4

Evidence

8
SS
Sahni Sanjeev SinghPresident
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$37K
891 sh
Apr 2, 2026Apr 3, 2026
traded Apr 2, 2026
+1dSEC Form 4

Evidence

8
RV
Raghavan VaidyanathanChief Technology Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$7,211
179 sh
Apr 2, 2026Apr 3, 2026
traded Apr 2, 2026
+1dSEC Form 4

Evidence

8
DS
Dutt SubirChief Sales Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$2,677
63 sh
Apr 2, 2026Apr 3, 2026
traded Apr 2, 2026
+1dSEC Form 4

Evidence

8
DS
Dutt SubirChief Sales Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$5,184
127 sh
Apr 2, 2026Apr 3, 2026
traded Apr 2, 2026
+1dSEC Form 4

Evidence

8
RV
Raghavan VaidyanathanChief Technology Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$6,160
145 sh
Apr 2, 2026Apr 3, 2026
traded Apr 2, 2026
+1dSEC Form 4

Evidence

8
SS
Sahni Sanjeev SinghPresident
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$4,078
96 sh
Apr 2, 2026Apr 3, 2026
traded Apr 2, 2026
+1dSEC Form 4

Evidence

7
KA
Kerdman AlinaSVP, Controller & CAO
CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP
Open-market sale · 10b5-1 plan
SELL$12K
194 sh
Apr 2, 2026Apr 3, 2026
traded Apr 2, 2026
+1dSEC Form 4

Evidence

5
SG
Steele Richard GSVP - General Counsel
MCOMOODYS CORP /DE/
Open-market sale · 10b5-1 plan
SELL$15K
34 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

1
RK
Ruddy Marcella K.Chief Medical Officer
TECXTectonic Therapeutic, Inc.
Open-market sale · 10b5-1 plan
SELL$31K
1,000 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

1
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$202K
1,000 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

1
MA
Majalya Sidney A.SVP, CLO and Secretary
TNETTRINET GROUP, INC.
Open-market sale · 10b5-1 plan
SELL$29K
775 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

1
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$194K
952 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

1
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$211K
1,048 sh
Apr 1, 2026Apr 3, 2026
traded Apr 1, 2026
+2dSEC Form 4

Evidence

51
Kelly MorrisonDSelf
ACAndersen Corporation
Partial sale
SELL$250K – $500KJan 20, 2026Apr 2, 2026
traded Jan 20, 2026
+72dHouse PTR

Evidence

51
Kelly MorrisonDSelf
ACAndersen Corporation
Partial sale
SELL$250K – $500KMar 15, 2025Apr 2, 2026
traded Mar 15, 2025
+383dHouse PTR

Evidence

51
Kelly MorrisonDSelf
ACAndersen Corporation
Partial sale
SELL$500K – $1.00MJan 20, 2025Apr 2, 2026
traded Jan 20, 2025
+437dHouse PTR

Evidence

51
Kelly MorrisonDSelf
ACAndersen Corporation
Partial sale
SELL$250K – $500KJun 15, 2025Apr 2, 2026
traded Jun 15, 2025
+291dHouse PTR

Evidence

50
SC
Skaff Michael C10% Owner
VVOSVivos Therapeutics, Inc.
Open-market purchase
BUY$2.39M
1.78M sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC Form 4

Evidence

50
SC
Skaff Michael C10% Owner
VVOSVivos Therapeutics, Inc.
Open-market purchase
BUY$1.40M
1.04M sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC Form 4

Evidence

50
SC
Skaff Michael C10% Owner
VVOSVivos Therapeutics, Inc.
Open-market purchase
BUY$2.39M
1.78M sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC Form 4

Evidence

47
SC
Skaff Michael C10% Owner
VVOSVivos Therapeutics, Inc.
Open-market purchase
BUY$576K
430.0K sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC Form 4

Evidence

45
Kelly MorrisonDSelf
ACAndersen Corporation
Partial sale
SELL$100K – $250KSep 15, 2025Apr 2, 2026
traded Sep 15, 2025
+199dHouse PTR

Evidence

45
Kelly MorrisonDSelf
ACAndersen Corporation
Partial sale
SELL$50K – $100KOct 15, 2025Apr 2, 2026
traded Oct 15, 2025
+169dHouse PTR

Evidence

43
SC
Skaff Michael C10% Owner
VVOSVivos Therapeutics, Inc.
Open-market purchase
BUY$414K
308.8K sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC Form 4

Evidence

43
Kelly MorrisonDSelf
FLFluxAI
Purchase
BUY$15K – $50KDec 22, 2025Apr 2, 2026
traded Dec 22, 2025
+101dHouse PTR

Evidence

39
Kelly MorrisonDSelf
CACavall
Purchase
BUY$1,001 – $15KDec 22, 2025Apr 2, 2026
traded Dec 22, 2025
+101dHouse PTR

Evidence

30
Kelly MorrisonDSelf
ACAndersen Corporation
Partial sale
SELL$100K – $250KMar 15, 2026Apr 2, 2026
traded Mar 15, 2026
+18dHouse PTR

Evidence

28
Kelly MorrisonDSelf
STStarCloud
Purchase
BUY$15K – $50KMar 15, 2026Apr 2, 2026
traded Mar 15, 2026
+18dHouse PTR

Evidence

26
MM
Mindlin Damian MiguelVice President
PAMPampa Energy Inc.
Open-market sale
SELL$1.78M
500.0K sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC Form 4

Evidence

26
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$332K
11.4K sh
Apr 1, 2026Apr 2, 2026
traded Apr 1, 2026
+1dSEC Form 4

Evidence

26
David J. TaylorRSelf
KRKROGER CO
Sale
SELL$1,001 – $15KMar 24, 2026Apr 2, 2026
traded Mar 24, 2026
+9dHouse PTR

Evidence

24
PE
Perros EvangelosChief Financial Officer
PGYPagaya Technologies Ltd.
Open-market sale
SELL$147K
13.0K sh
Apr 1, 2026Apr 2, 2026
traded Apr 1, 2026
+1dSEC Form 4

Evidence

23
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$101K
3,348 sh
Apr 1, 2026Apr 2, 2026
traded Apr 1, 2026
+1dSEC Form 4

Evidence

22
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$1.90M
49.3K sh
Apr 1, 2026Apr 2, 2026
traded Apr 1, 2026
+1dSEC Form 4

Evidence

22
RV
Raghunathan VivekSVP, Engineering
SNOWSnowflake Inc.
Open-market sale · 10b5-1 plan
SELL$592K
3,876 sh
Apr 1, 2026Apr 2, 2026
traded Apr 1, 2026
+1dSEC Form 4

Evidence